Several brokerages have updated their recommendations and price targets on shares of Smith & Nephew (LON: SN) in the last few weeks:
- 2/9/2018 – Smith & Nephew had its price target raised by analysts at Credit Suisse Group AG from GBX 1,285 ($17.75) to GBX 1,290 ($17.82). They now have a “neutral” rating on the stock.
- 2/7/2018 – Smith & Nephew had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a GBX 1,411 ($19.49) price target on the stock.
- 2/1/2018 – Smith & Nephew had its “overweight” rating reaffirmed by analysts at JPMorgan Chase & Co.. They now have a GBX 1,411 ($19.49) price target on the stock.
- 1/25/2018 – Smith & Nephew was upgraded by analysts at JPMorgan Chase & Co. to an “overweight” rating. They now have a GBX 1,411 ($19.49) price target on the stock, up previously from GBX 1,369 ($18.91).
Shares of Smith & Nephew plc (LON:SN) traded up GBX 23 ($0.32) during mid-day trading on Monday, reaching GBX 1,250 ($17.27). 2,532,748 shares of the company traded hands, compared to its average volume of 2,840,000. Smith & Nephew plc has a 1 year low of GBX 1,173 ($16.21) and a 1 year high of GBX 1,442 ($19.92). The firm has a market capitalization of $10,940.00 and a price-to-earnings ratio of 1,984.13.
The business also recently declared a dividend, which will be paid on Wednesday, May 9th. Investors of record on Thursday, April 5th will be given a dividend of $0.23 per share. This is a positive change from Smith & Nephew’s previous dividend of $0.12. The ex-dividend date is Thursday, April 5th. This represents a yield of 1.34%.
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.